- Home
- SPR vs DNLI Comparison
SPR vs DNLI Comparison
Compare SPR & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPR
- DNLI
- Stock Information
- Founded
- SPR 1927
- DNLI 2013
- Country
- SPR United States
- DNLI United States
- Employees
- SPR N/A
- DNLI N/A
- Industry
- SPR Military/Government/Technical
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPR Industrials
- DNLI Health Care
- Exchange
- SPR Nasdaq
- DNLI Nasdaq
- Market Cap
- SPR 3.7B
- DNLI 3.3B
- IPO Year
- SPR 2006
- DNLI 2017
- Fundamental
- Price
- SPR $33.91
- DNLI $21.93
- Analyst Decision
- SPR Hold
- DNLI Strong Buy
- Analyst Count
- SPR 16
- DNLI 13
- Target Price
- SPR $35.67
- DNLI $38.91
- AVG Volume (30 Days)
- SPR 1.2M
- DNLI 1.1M
- Earning Date
- SPR 02-04-2025
- DNLI 02-25-2025
- Dividend Yield
- SPR N/A
- DNLI N/A
- EPS Growth
- SPR N/A
- DNLI N/A
- EPS
- SPR N/A
- DNLI N/A
- Revenue
- SPR $6,478,200,000.00
- DNLI N/A
- Revenue This Year
- SPR $6.60
- DNLI N/A
- Revenue Next Year
- SPR $25.00
- DNLI $651.24
- P/E Ratio
- SPR N/A
- DNLI N/A
- Revenue Growth
- SPR 16.62
- DNLI 204.74
- 52 Week Low
- SPR $25.16
- DNLI $14.56
- 52 Week High
- SPR $37.08
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- SPR 57.44
- DNLI 51.28
- Support Level
- SPR $33.61
- DNLI $18.52
- Resistance Level
- SPR $34.44
- DNLI $22.37
- Average True Range (ATR)
- SPR 0.63
- DNLI 1.31
- MACD
- SPR -0.03
- DNLI 0.31
- Stochastic Oscillator
- SPR 65.13
- DNLI 88.57
About SPR Spirit Aerosystems Holdings Inc.
Spirit AeroSystems manufactures aerostructures, particularly fuselages, cockpits, wing sections, engine pylons, and nacelles for commercial and military aircraft. The company was spun out of Boeing in 2005, and the firm is the largest independent supplier of aerostructures for commercial aircraft. Boeing and Airbus are the firm's primary customers—Boeing represented roughly 60% and Airbus roughly 20% of revenue in recent years. The company is highly exposed to Boeing's beleaguered 737 program, which accounts for nearly half the company's revenue.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.